Cardiac function improvement 24 hours after Isradipine SRO in patients with chronic stable angina: A double-blind randomized study

Acta Cardiologica

Volumn 51, Issue 2, 1996, Pages 155-164

  Doat, M ^a   Hacot, J P ^a   Pavin, D ^a   Righetti, A ^a,b  

^a UNIVERSITY HOSPITAL   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Gated radionuclide angiography; Isradipine SRO; Stress test

Indexed keywords

CALCIUM ANTAGONIST; ISRADIPINE;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ELECTROCARDIOGRAPHY; EXERCISE; FEMALE; HEART EJECTION FRACTION; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE FILLING; HEART VENTRICLE FUNCTION; HUMAN; MALE; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; SCINTIANGIOGRAPHY; ST SEGMENT DEPRESSION; SUSTAINED RELEASE PREPARATION; SYMPTOM; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; ANGINA PECTORIS; CALCIUM CHANNEL BLOCKERS; DOUBLE-BLIND METHOD; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; GATED BLOOD-POOL IMAGING; HEART; HUMANS; ISRADIPINE; MALE; MIDDLE AGED; STROKE VOLUME; TREATMENT OUTCOME; VENTRICULAR FUNCTION;

EID: 0029946046     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. BURGER, W., HERHOLZ, H , BURGER, K. & KOBER, G. - Anti-ischemic and hemodynamic effects of intravenous isradipine, a new calcium antagonist, in coronary heart disease: A comparative double-blind cross-over study with nifedipine. J. Cardiovasc. Pharmacol., 1990, 16 (5), 764.
2. CARRERA, R., VRAN, F., MAZZOLA, C , VACCARELLA, A., PACIARONI, E., FERRONI, C. & MILANI, M. - Isradipine sustained release once daily in the treatment of mild to moderate hypertension in the elderly Curr. Ther Res Clin. Exp., 1992, 51 (2), 281
3. CELENTANO, A., GALDERISI, M., TAMMARO, P., MUREDDU, G., GAROFALO, M., DE SIMONE, G., & DE VITIIS O. et al - Slow release Isradipine in mild to moderate hypertension: Hemodynamic and antihypertensive effects. Int. J. Clin. Pharmacol., 1991, 29, 494.
4. DELONCA, J., KIPFER, P. & RIGHETTI, A. - Effects of oral isradipine on left ventricular function at rest and during exercise in patients with stable chronic angina: A double-blind, placebo-controlled crossover study. J. Cardiovasc. Pharmacol., 1992, 19 (1), 126.
5. D'HONT, G , MEURANT, J. P., CLEMENT, D. L., RORIVE, G., HERMANS, L., DE KEYSER, P. & WESTERLINC, K. J. - Long-term (2 years) isradipine data in the treatment of mild-to-moderate hypertension. J. Cardiovasc. Pharmacol , 1992, 19 (suppl. 3), S46.
6. EDWARDS, L. C. III & LOUIE, E. K. - Pharmacologic management of stable angina. Hosp.-Formul., 1992, 27 (4), 355
7. FOGARI, R., MALOCCO, E., TETTAMANTI, G., GNEMMI, A. E & MILANI, M. - Evening versus morning isradipine sustained release in essential hypertension: A double-blind study with 24 ambulatory monitoring. Br. J. Clin. Pharmacol., 1993, 35 (1), 51.
8. HOFF, R. P., SELZMANN, R. & SIEGL, H. - Selective effects of PM 200-110 (isradipine) on the peripheral circulation and the heart. Am. J. Cardiol., 1987, 59, 30B.
9. JOHNSON, D. L., LESOWAY, R., HUMEN, D. P. & KOSTUK, W. J - Clinical and hemodynamic evaluation of propranolol in combination with verapamil, nifedipine and diltiazem in exertional angina pectoris: a placebo-controlled, double-blind, randomized cross-over study. Am. J. Cardiol., 1985, 55, 680
10. LYNCH, P., DARGIE, H. & KRINKLER, D. - Objective assessment of anti-anginal treatment. a double-blind evaluation of propranolol, nifedipine and their combination Br. Med. J., 1980, 281, 184.
11. MAUSER, M., VOELKER, W., ICKRATH, O. & KARSCH, K R. - Differences of myocardial properties of the new dihydropiridine calcium channel blocker isradipine as compared to nifedipine with or without additional beta blockade in patients with coronary artery disease. Am. J. Cardiol., 1989, 63, 40.
12. MILLER, H. - Isradipine: overall clinical experiences in hypertension in the United States. J. Cardiovasc. Pharmacol., 1990, Suppl. 1, S60
13. MITROVIC, V., RIECKMANN, C., KORNECKI, P., BURGER, K. J., WELZEL, D. & SCHLEPPER, M. - Effects of the calcium antagonist, isradipine, and nifedipine on resting and exercise haemodynamics and neuronal system in patients with stable chronic angina. Eur. Heart J., 1990, 11 (5), 454
14. PERSONN, B., WYSOCKI, M. & ANDERSSON, O. K. - Long-term renal effects of Isradipine, a calcium entry blocker, in essential hypertension. J. Cardiovasc. Pharmacol., 1989, 14, 22.
15. PEDERSEN, O L., KRUSELL, L. R., SIEHM, L. JEPERSEN, L. T. & THOMSEN, K. - Long-term effects of isradipine on blood pressure and renal function. Am. J. Med., 1989, 84 (suppl. 3 B), 15.
16. SHERMAN, L. & LIANG, C. S - Nifedipine in chronic stable angina: a double-blind placebo-controlled cross-over trial. Am. J. Cardiol., 1983, 51, 706.
17. WADA, Y., SATOH, K. & TAITA, N. - A study on the separation of the coronary vasodilator from cardiac effects of PN 200-110, a new dihydropyridine calcium antagonist, in the dog heart. J. Cardiovasc Pharmacol., 1985, 7, 190.
18. VAN WIJK, L. M., TOREN, W. E , VAN GELDER, I., CRIJNS, H J , RUEGG, P. & LIE, K I - Electrophysiological properties of isradipine (PN 200-110) in humans. J Cardiovasc. Pharmacol., 1989, 14, 492.
19. RUPOLI, L., FRUSCIO, M , GRANDNICK, R., CHIANCA, R., LEONETTI, G. & ZANCHETTI, A - Cardiovascular and renal effects of single administration of three different doses of isradipine in hypertensive patients. Am. J. Med., 1989, 86, 65.
20. RUEGG, P C. & NELSON, D. J. - Safety and efficacy of Isradipine, alone and in combination, in the treatment of angina pectoris Am. J. Med. 1989, 86(4A), 70.
21. STRUYKER-BOUDIER, H. A. J., SMITS, J. F. M., DE MEY, J. G. R. - The pharmacology of calcium antagonists, a review. J. Cardiovasc. Pharmacol., 1990, 14, 22.
22. ZANCHETTI, A. & LEONETTI, G. - Natriuretic effects of calcium antagonists clinical implications. Drugs, 1990, 40 (suppl. 2), 15.